Abstract
The aim of the present study was to investigate the age-related patterns and the relationship between levels of urinary cross-linked N-telopeptide of type-I collagen (NTx) and heel stiffness index measured by quantitative ultrasound (QUS) in men with a special reference to age groups of aged 40 to 59 years and ≥60 years.
A total of 379 men participated in this study. Heel stiffness index (bone mass) was measured by QUS. Spot urine samples were collected, and urinary NTx was measured. The values were corrected for creatinine (Cre) concentration.
Stiffness index was significantly lower in men aged ≥60 years compared with men aged 40 to 59 years (P < 0.0001). There was no significant difference of Log (NTx/Cre) by 10-year age groups. Multiple regression analysis showed that higher level of urinary NTx/Cre was significantly correlated with lower stiffness index after adjusting for age and body mass index in men aged ≥60 years, but not in men aged 40 to 59 years.
Higher rates of bone resorption were associated with lower stiffness index only in elderly men. Our results may indicate a different mechanism of low bone mass among different age groups.
INTRODUCTION
Osteoporosis and resulting fractures impair the activities of daily living and quality of life, leading to increased morbidity and mortality in the elderly.1,2 Although osteoporosis is more common in women, men have substantial age-related decreases in bone mineral density (BMD).3–5 Thus, osteoporosis in men is also a significant public health problem because of the rapid aging of society.
Cross-linked N-telopeptide of type-I collagen (NTx) is one of the biochemical markers of bone resorption, and is widely used in clinical situations to evaluate the indication and efficacy of treatments for osteoporosis.6–8 Previous studies showed that the serum or urinary concentration of NTx increased after menopause in women.5,9–11 From 40 years on, age-related patterns of NTx in men have been controversial. Some studies reported that NTx increased with age,10,12 but the others reported that NTx was stable.5,13–15
Several studies reported that NTx correlated inversely and significantly with BMD at some skeletal sites in men,10,13 but these correlations were weaker than those in women.10 On the contrary, data on relationship between bone turnover marker and bone quantitative ultrasound (QUS) measurement are limited, especially in men. QUS is a developed promising technique for evaluation of fracture risk and bone mineral status. In addition to the features of portability, relatively low cost, and ease to use, QUS is also free from ionizing radiation and provides information on bone structure.16 Therefore, QUS has been widely used in Japan for screening patients at high risk of osteoporotic fractures.17,18 Recently, Boonen et al19 showed that higher levels of bone markers serum N-terminal propeptide of type 1 procollagen and β-isomerized C-terminal telopeptides were significantly associated with lower QUS parameters among men aged 40 to 79 years; however, the study was conducted among combining middle-aged and elderly men. Thus, the relationship between NTx and bone mass (QUS) in men is still unclear, and there were few studies with references to age groups.20
The aim of the present study was to investigate the age-related patterns and the relationship between levels of urinary NTx and heel stiffness index measured by QUS in men with a special reference to age groups (40–59 years, and ≥60 years).
METHODS
The subjects were community-dwelling men aged ≥40 years at Nagasaki Prefecture, Japan, who were invited to participate in periodic health examinations in 2006 to 2009. A total of 379 men participated in this study. All subjects gave written informed consent before examination. This study was approved by the Institutional Review Board of Nagasaki University.
Heel stiffness index (bone mass) by QUS was measured using a Lunar Achilles device (GE Lunar Corp., Madison, WI). Spot urine samples (8:00–10:00 am) were collected. Urinary NTx, a marker of bone resorption, was measured with enzyme immunoassay. The values were corrected for creatinine (Cre) concentration. Height (m) and weight (kg) were measured with light clothing and without shoes, and body mass index (BMI) was calculated as weight (kg)/height2 (m2).
Statistical Analysis
The data were analyzed using the Statistical Analysis System software package version 9.2 (SAS Institute, Cary, NC). Because NTx/Cre was not normally distributed, NTx/Cre was treated as Log (NTx/Cre). Student t test was used to examine the difference in variables between the age groups. One-way ANOVA was used to Log (NTx/Cre) between 10-year age groups. Simple correlation analysis was used to examine the correlation between the levels of NTx/Cre and stiffness index. Multiple linear regression analysis was used to explore the effect of age, BMI and Log (NTx/Cre) on stiffness index. A P value of <0.05 was considered as statistically significant.
RESULTS
Table 1 shows the characteristics of our 379 subjects. Weight and height were significantly smaller in men aged ≥60 years compared with men aged 40 to 59 years (P < 0.0001). Stiffness index was significantly lower in men aged ≥60 years compared with men aged 40 to 59 years (P < 0.0001). There was no significant difference of BMI and Log (NTx/Cre) between age groups.
TABLE 1.
Characteristics of the Study Subjects (n = 379)
In the one-way ANOVA, there was no significant difference of Log (NTx/Cre) by 10-year age groups (P = 0.12) (Table 2).
TABLE 2.
Mean (SD) of Log (NTx/Cre) by Age Group
In men aged over 60 years, there was a significant negative correlation between the levels of urinary NTx/Cre and stiffness index, but not in men aged 40 to 59 years (Figure 1).
FIGURE 1.
(A) Correlation between Log (NTx/Cre) and stiffness index in 40 to 59 age group (r = 0.038, P = 0.72). (B) Correlation between Log (NTx/Cre) and stiffness index in ≥60 age group (r = −0.310, P < 0.0001).
In order to assess further the independent relationship, we used a multiple regression analysis. It showed that higher level of urinary NTx/Cre was significantly correlated with lower stiffness index (QUS) after adjusting for age and BMI in men aged ≥60 years, but not in men aged 40 to 59 years (Table 3). In addition, NTx/Cre was also significantly correlated with lower stiffness index (QUS) after adjusting for age and height/weight in men aged ≥60 years (data not shown).
TABLE 3.
Multiple Linear Regression Analysis of Stiffness Index
DISUCUSSION
We showed that higher level of urinary NTx was significantly correlated with lower stiffness index (QUS) after adjusting for age and BMI in men aged ≥60 years, but not in men aged 40 to 59 years. Boonen et al19 reported that higher levels of bone markers were significantly associated with lower QUS parameters among middle-aged and elderly men combined, but did not analyze with a special reference to middle-aged or elderly men. To the best of our knowledge, we first reported the significant correlation between NTx and stiffness index (QUS) only in elderly men, not in middle-aged men.
We showed no significant differences of urinary NTx among 10-year age groups, which is consistent with previous reports in men aged ≥40 years.5,14,15 In women, NTx values increase with the decline in estrogen production at the time of menopause and remain elevated thereafter.21 Because men do not have the equivalent of menopause, NTx may not increase rapidly in men. However, some studies reported increasing of NTx with age in middle-aged and elderly men.10,12 Further study is needed to explore the age-related patterns of NTx in middle-aged and elderly men.
Our results showed significant and negative correlation between NTx and stiffness index (QUS) only in men aged ≥60 years. Khosla et al10 showed significant and negative association between proximal femur BMD and serum NTx in men aged ≥50 years, but not in men <50 years. Chandani et al13 showed that higher serum NTx correlated with lower femoral neck BMD in men aged 68 to 89 years. These findings suggest that higher rates of bone resorption are associated with lower bone mass, especially in elderly men.
In elderly men, slightly increased bone resorption is not matched by a parallel increase in bone formation, and this imbalance results in the age-related bone loss.20 Unfortunately, bone formation marker was not measured in our study. It is needed to evaluate both resorption and formation markers to understand more detailed mechanisms of osteoporosis in elderly men.
Our study has several limitations. First, because this study was cross-sectional design, our results do not necessarily show a causal relationship. Second, information on other determinants (eg, genetic background, nutritional status, socioeconomic status, medication [ex. corticosteroids], levels of Vitamin D, and underlying comorbidities) contributing to skeletal maintenance in aging men19 was not available to our study. Finally, the subjects were participants of health examination and may not be representative of the general population.
In conclusion, we showed that higher level of urinary NTx was significantly correlated with lower stiffness index (QUS) in men aged ≥60 years, but not in men aged 40 to 59 years. Higher rates of bone resorption were associated with lower stiffness index only in elderly men. Our results may indicate different mechanisms of low stiffness index among different age groups.
Footnotes
Abbreviations: BMD = bone mineral density, BMI = body mass index, Cre = creatinine, NTx = cross-linked N-telopeptide of type-I collagen, QUS = quantitative ultrasound.
The authors have no funding and conflicts of interest to disclose.
REFERENCES
- 1.Johnell O, Kanis J, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int 2004; 15:38–42. [DOI] [PubMed] [Google Scholar]
- 2.Muraki S, Yamamoto S, Ishibashi H, et al. Factors associated with mortality following hip fracture in Japan. J Bone Miner Metab 2006; 24:100–104. [DOI] [PubMed] [Google Scholar]
- 3.Jones G, Nguyen T, Sambrook P, et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309:691–695. [PMC free article] [PubMed] [Google Scholar]
- 4.Riggs BL, Wahner HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67:328–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yoshimura N, Muraki S, Oka H, et al. Changes in serum levels of biochemical markers of bone turnover during 10 years among Japanese men and women: associated factors and birth-cohort effect. The Taiji Study. J Bone Miner Metab 2011; 29:699–708. [DOI] [PubMed] [Google Scholar]
- 6.Morii H, Ohashi Y, Taketani Y, et al. Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int 2003; 14:793–800. [DOI] [PubMed] [Google Scholar]
- 7.Rizzoli R. Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 2002; 17:1988–1996. [DOI] [PubMed] [Google Scholar]
- 8.Rosen CJ, Hochberg MC, Bonnick SL, et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res 2005; 20:141–151. [DOI] [PubMed] [Google Scholar]
- 9.Garnero P, Sornay-Rendu E, Chapuy MC, et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996; 11:337–349. [DOI] [PubMed] [Google Scholar]
- 10.Khosla S, Melton LJ, III, Atkinson EJ, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen 1. J Clin Endocrinol Metab 1998; 83:2266–2274. [DOI] [PubMed] [Google Scholar]
- 11.Melton LJ, Khosla S, Atkinson EJ, et al. Relationship of bone turnover to bone density and fractures. J Bone Miner Res 1997; 12:1083–1091. [DOI] [PubMed] [Google Scholar]
- 12.Gallagher JC, Kinyamu HK, Fowler SE, et al. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 1998; 13:475–482. [DOI] [PubMed] [Google Scholar]
- 13.Chandani AK, Scariano JK, Glew RH, et al. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men. Bone 2000; 26:513–518. [DOI] [PubMed] [Google Scholar]
- 14.Fatayerji D, Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res 1999; 14:1203–1210. [DOI] [PubMed] [Google Scholar]
- 15.Sone T, Miyake M, Takeda N, et al. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits. Bone 1995; 17:335–339. [DOI] [PubMed] [Google Scholar]
- 16.Genant HK, Engelke K, Fuerst T, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996; 11:707–730. [DOI] [PubMed] [Google Scholar]
- 17.Fujiwara S, Sone T, Yamazaki K, et al. Heel bone ultrasound predicts non-spine fracture in Japanese men and women. Osteoporos Int 2005; 16:2107–2112. [DOI] [PubMed] [Google Scholar]
- 18.Yoshimi I, Aoyagi K, Okano K, et al. Stiffness index of the calcaneus measured by quantitative ultrasound and menopause among Japanese women: the Hizen-Oshima Study. Tohoku J Exp Med 2001; 195:93–99. [DOI] [PubMed] [Google Scholar]
- 19.Boonen S, Pye SR, O’Neill TW, et al. Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS). Eur J Endocrinol 2011; 165:977–986. [DOI] [PubMed] [Google Scholar]
- 20.Szulc P, Garnero P, Munoz F, et al. Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001; 16:1642–1650. [DOI] [PubMed] [Google Scholar]
- 21.Orwoll ES, Bell NH, Nanes MS, et al. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab 1998; 83:3930–3935. [DOI] [PubMed] [Google Scholar]